financetom
Business
financetom
/
Business
/
Nvidia's $500 Billion AI Infrastructure Investment May Ease Circular Financing Concerns, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nvidia's $500 Billion AI Infrastructure Investment May Ease Circular Financing Concerns, Morgan Stanley Says
Aug 11, 2026 8:10 AM

10:52 AM EDT, 08/11/2026 (MT Newswires) -- Nvidia ( NVDA ) is mobilizing up to $500 billion to fund artificial intelligence infrastructure, with limited co-investment support, while addressing circular financing concerns, Morgan Stanley said in a note Tuesday.

The company said Monday it is collaborating with Apollo (APO), BlackRock (BLK), Blackstone (BX), Brookfield (BN), Goldman Sachs (GS) and KKR (KKR) to launch this investment initiative.

Chief Executive Jensen Huang said on X that the initiative is designed to address concerns around "circularity." If the company's participation is limited to 25% or less, while third-party investors make the primary investment decisions, this could help ease concerns that Nvidia's ( NVDA ) investments are driven mainly by circular financing motivations, Morgan Stanley said.

The bank said that there are still important unknowns. The $500 billion figure represents the total potential investment capacity, not committed funding. Individual projects will still be evaluated on their own merits, so there is no guarantee that these funds are deployed.

"The Nvidia ( NVDA ) co-investment also could become complicated. In our view, we would prefer a backstop which involves GPU usage rather than pure credit backing," it added.

Morgan Stanley has an overweight rating and a $288 price target on Nvidia ( NVDA ).

Price: 219.03, Change: +1.47, Percent Change: +0.68

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Labcorp Holdings Launches FDA-Cleared Blood Test Lumipulse to Help Diagnose Alzheimer's Disease
Labcorp Holdings Launches FDA-Cleared Blood Test Lumipulse to Help Diagnose Alzheimer's Disease
Aug 18, 2025
07:39 AM EDT, 08/18/2025 (MT Newswires) -- Labcorp Holdings ( LH ) said Monday that Lumipulse, the first blood test cleared by the US Food and Drug Administration to help diagnose Alzheimer's disease, is now available nationwide. The test offers results that are comparable to existing methods, but is less invasive and more affordable and accessible, the company said. Lumipulse...
Trident Digital Tech Acquires 30% Stake in Tongxin for $3 Million
Trident Digital Tech Acquires 30% Stake in Tongxin for $3 Million
Aug 18, 2025
07:39 AM EDT, 08/18/2025 (MT Newswires) -- Trident Digital Tech ( TDTH ) said Monday that it has agreed to acquire a 30% equity stake in Tongxin Innovation for approximately $3 million. Tongxin Innovation operates the ToMe Web 3.0 e-commerce platform on Telegram. The company said the deal, which values Tongxin at approximately $10 million, will be completed by issuing...
International Petroleum Released Results of Latest Normal Course Issuer Bid
International Petroleum Released Results of Latest Normal Course Issuer Bid
Aug 18, 2025
07:47 AM EDT, 08/18/2025 (MT Newswires) -- International Petroleum ( IPCFF ) earlier on Monday announced that it repurchased a total of 144,952 common shares during the period of August 11 to 15, 2025 under its normal course issuer bid, share repurchase program (NCIB). During the period, IPC repurchased a total of 88,052 IPC common shares on Nasdaq Stockholm. During...
FibroGen Says China Unit Sale to AstraZeneca Receives Regulatory Approval
FibroGen Says China Unit Sale to AstraZeneca Receives Regulatory Approval
Aug 18, 2025
07:44 AM EDT, 08/18/2025 (MT Newswires) -- FibroGen ( FGEN ) said Monday the China State Administration for Market Regulation has approved the sale of its subsidiary in China to AstraZeneca ( AZN ) unit AstraZeneca Treasury. FibroGen ( FGEN ) said the transaction remains on track to close in Q3, pending other contractual conditions and deliverables. FibroGen ( FGEN...
Copyright 2023-2026 - www.financetom.com All Rights Reserved